Are you Dr. Austin?
Join over one million U.S. Physicians, Nurse Practitioners and PAs, already on Doximity.
- Gain access to free telehealth tools, such as our "call shielding" and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
You already have 41 invites waiting! - Read the latest clinical news, personalized to your specialty.
Office
11801 Trailridge Dr
Potomac, MD 20854Phone+1 240-418-5708
Summary
- Dr. Christopher Austin, MD is a board certified neurologist in Potomac, Maryland. He is currently licensed to practice medicine in Maryland, Pennsylvania, and Massachusetts.
Education & Training
- Brigham and Women's Hospital/Massachusetts General Hospital/Harvard Medical SchoolResidency, Neurology, 1987 - 1990
- Massachusetts General HospitalResidency, Internal Medicine, 1986 - 1987
- Harvard Medical SchoolClass of 1986
Certifications & Licensure
- MD State Medical License 2003 - 2026
- PA State Medical License 1996 - 2006
- MA State Medical License 1990 - 2004
- American Board of Psychiatry and Neurology Neurology
Publications & Presentations
PubMed
- 25 citationsInternational collaborative actions and transparency to understand, diagnose, and develop therapies for rare diseases.Kym M. Boycott, Lilian P.L. Lau, Christine M. Cutillo, Christopher P. Austin
EMBO Molecular Medicine. 2019-05-01 - 189 citationsOverexpression of M68/DcR3 in human gastrointestinal tract tumors independent of gene amplification and its location in a four-gene clusterChang Bai, Brett Connolly, Michael L. Metzker, Catherine A. Hilliard, Xiaomei Liu
Proceedings of the National Academy of Sciences of the United States of America. 2000-02-01 - 181 citationsTherapies for rare diseases: therapeutic modalities, progress and challenges ahead.Erik Tambuyzer, Benjamin Vandendriessche, Christopher P. Austin, Philip J. Brooks, Kristina Larsson
Nature Reviews. Drug Discovery. 2020-02-01
Press Mentions
- Feds Now See the Need for Funding Antivirals: TrialSite Will Track the Spend CarefullyJune 18th, 2021
- CURE ID Launched by FDA to Open up Crowdsourcing for Repurposing of Approved Drugs for Novel Uses in Rare DiseaseDecember 9th, 2019
- FDA Launches New App to Crowdsource Difficult-to-Treat Infectious DiseasesDecember 5th, 2019
- Join now to see all